Total Media News

UE a aprobat folosirea vaccinului Pfizer in UE PDF Imprimare
Luni, 21 Decembrie 2020 21:31


EMA Logo

   Agenţia Europeană pentru Medicamente (EMA) a dat undă verde vaccinului anti-coronavirus

    Vaccinul produs de BioNTech și Pfizer împotriva noului coronavirus poate fi utilizat în UE. Astfel a decis Agenţia Europeană pentru Medicamente  si  a  primit  aprobarea  si de la Comisia  Europeana.

    MA has recommended granting a conditional marketing authorisation for the vaccine Comirnaty, developed by BioNTech and Pfizer, to prevent coronavirus disease 2019 (COVID-19) in people from 16 years of age. EMA’s scientific opinion paves the way for the first marketing authorisation of a COVID-19 vaccine in the EU by the European Commission, with all the safeguards, controls and obligations this entails.

EMA’s human medicines committee (CHMP) has completed its rigorous evaluation of Comirnaty, concluding by consensus that sufficiently robust data on the quality, safety and efficacy of the vaccine are now available to recommend a formal conditional marketing authorisation. This will provide a controlled and robust frameworerk to underpin EU-wide vaccination campaigns and protect EU citizens.


Magazin specializat piese auto
Service Auto autorizat RAR
Uleiuri Auto
Baterii auto
Salonul Auto Bucuresti 2021
Bucharest FAshion Week 2015

Sunteti aici: Home Economie Companii UE a aprobat folosirea vaccinului Pfizer in UE